The prospective, randomized, multicenter clinical study of the efficacy and safety of Raltitrexed combined with Irinotecan(SALIRI) compared with FOLFIRI second-line treatment in the treatment of advanced colorectal cancer
收藏NIAID Data Ecosystem2026-03-11 收录
官方服务：
资源简介：
Interventions: Experimental group:SALIRI;Control group:FOLFIRI Primary outcome(s): PFS Study Design: Non randomized control
创建时间：
2019-12-15
